SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-058294
Filing Date
2014-09-16
Accepted
2014-09-16 19:30:38
Documents
1
Period of Report
2014-09-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 9139
  Complete submission text file 0001209191-14-058294.txt   10498
Mailing Address 1 Broadway 14TH FLOOR Cambridge MA 02142
Business Address 1 Broadway 14TH FLOOR Cambridge MA 02142 617-225-4348
Tokai Pharmaceuticals Inc (Issuer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SUITE 4 LEVEL 46 2 PARK STREET SIDNEY C3 2000
Business Address
Wade Denis Newell (Reporting) CIK: 0001404735 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36620 | Film No.: 141106555